Simpo, Florencia M.
HRN: 22-59-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/31/2023
04/06/2023
IV
750 Mg
OD
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes